534 related articles for article (PubMed ID: 16838224)
41. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
42. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588
[TBL] [Abstract][Full Text] [Related]
43. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
44. Fatal Trichosporon fungemia in patients with hematologic malignancies.
Suzuki K; Nakase K; Kyo T; Kohara T; Sugawara Y; Shibazaki T; Oka K; Tsukada T; Katayama N
Eur J Haematol; 2010 May; 84(5):441-7. PubMed ID: 20059528
[TBL] [Abstract][Full Text] [Related]
45. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Wagner D; Sander A; Bertz H; Finke J; Kern WV
Infection; 2005 Oct; 33(5-6):397-400. PubMed ID: 16258877
[TBL] [Abstract][Full Text] [Related]
46. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
47. Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
Chan-Tack KM
South Med J; 2005 Sep; 98(9):954-5. PubMed ID: 16217998
[No Abstract] [Full Text] [Related]
48. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
49. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report.
Shang ST; Yang YS; Peng MY
J Microbiol Immunol Infect; 2010 Feb; 43(1):77-80. PubMed ID: 20434128
[TBL] [Abstract][Full Text] [Related]
50. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
51. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Sili U; Yilmaz M; Ferhanoglu B; Mert A
Clin Infect Dis; 2007 Oct; 45(7):897-8. PubMed ID: 17806057
[TBL] [Abstract][Full Text] [Related]
52. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
53. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
[TBL] [Abstract][Full Text] [Related]
54. Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
Sundaram M; Anandbabu K; Basu G; Devasia A; Tamilarasi V
Transplantation; 2010 Sep; 90(5):588-9. PubMed ID: 20814301
[No Abstract] [Full Text] [Related]
55. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
56. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
57. Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
Saitoh T; Matsushima T; Shimizu H; Yokohama A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Ann Hematol; 2007 Sep; 86(9):697-8. PubMed ID: 17431625
[No Abstract] [Full Text] [Related]
58. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
59. Advances in antifungal therapy.
Pannaraj PS; Walsh TJ; Baker CJ
Pediatr Infect Dis J; 2005 Oct; 24(10):921-2. PubMed ID: 16220093
[No Abstract] [Full Text] [Related]
60. A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery.
Izumi K; Hisata Y; Hazama S
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):350-3. PubMed ID: 19901894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
